Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report
This case suggests that the early administration of anti-interleukin-5 receptor antibody therapy may be a valuable treatment option for refractory thrombosis.
Authors
- Atsushi Kumanogoh (ORCID: https://orcid.org/0000-0003-4749-7117)
- Yujiro Naito
- Masayoshi Higashiguchi (ORCID: https://orcid.org/0000-0002-0617-1244)
- Satoshi Tetsumoto
- Atsushi Yanagisawa (ORCID: https://orcid.org/0009-0002-1937-3782)
- Daiki Nagira
- Hanako Yoshimura (ORCID: https://orcid.org/0000-0002-3717-3963)
- Yoshito Takeda (ORCID: https://orcid.org/0000-0003-2905-6537)
- Kensuke Kanaoka
- Atsushi Funauchi
- Shimpei Miyamoto (ORCID: https://orcid.org/0000-0003-4367-6927)
- Haruhiko Hirata (ORCID: https://orcid.org/0000-0002-1134-7283)
- Takayuki Shiroyama (ORCID: https://orcid.org/0000-0002-2816-9428)
- Tatsunori Jo (ORCID: https://orcid.org/0000-0001-5435-3723)
- T. Mizukoshi
Institutions
- Suita Municipal Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Allergy Asthma and Clinical Immunology
- Published
- 2025-05-17
- DOI
- https://doi.org/10.1186/s13223-025-00967-2
- Citations
- 2
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 3.34